These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro. Morokutti-Kurz M; Fröba M; Graf P; Große M; Grassauer A; Auth J; Schubert U; Prieschl-Grassauer E PLoS One; 2021; 16(2):e0237480. PubMed ID: 33596218 [TBL] [Abstract][Full Text] [Related]
6. Iota-carrageenan and xylitol inhibit SARS-CoV-2 in Vero cell culture. Bansal S; Jonsson CB; Taylor SL; Figueroa JM; Dugour AV; Palacios C; Vega JC PLoS One; 2021; 16(11):e0259943. PubMed ID: 34797868 [TBL] [Abstract][Full Text] [Related]
7. Iota-Carrageenan Inhibits Replication of SARS-CoV-2 and the Respective Variants of Concern Alpha, Beta, Gamma and Delta. Fröba M; Große M; Setz C; Rauch P; Auth J; Spanaus L; Münch J; Ruetalo N; Schindler M; Morokutti-Kurz M; Graf P; Prieschl-Grassauer E; Grassauer A; Schubert U Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947999 [TBL] [Abstract][Full Text] [Related]
8. In vitro and clinical studies on the efficacy of α-cyclodextrin and hydroxytyrosol against SARS-CoV-2 infection. Paolacci S; Ergoren MC; De Forni D; Manara E; Poddesu B; Cugia G; Dhuli K; Camilleri G; Tuncel G; Kaya Suer H; Sultanoglu N; Sayan M; Dundar M; Beccari T; Ceccarini MR; Gunsel IS; Dautaj A; Sanlidag T; Connelly ST; Tartaglia GM; Bertelli M Eur Rev Med Pharmacol Sci; 2021 Dec; 25(1 Suppl):81-89. PubMed ID: 34890038 [TBL] [Abstract][Full Text] [Related]
9. Natural Derived Nasal Spray; A Proposed Approach for COVID-19 Disease Control. Hoseini-Tavassol Z; Ejtahed HS; Soroush AR; Sajjadpour Z; Hasani-Ranjbar S; Larijani B Infect Disord Drug Targets; 2021; 21(8):e160921191568. PubMed ID: 33602078 [TBL] [Abstract][Full Text] [Related]
10. Low Acyl Gellan as an Excipient to Improve the Sprayability and Mucoadhesion of Iota Carrageenan in a Nasal Spray to Prevent Infection With SARS-CoV-2. Robinson TE; Moakes RJA; Grover LM Front Med Technol; 2021; 3():687681. PubMed ID: 35047933 [TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 inhibition using a mucoadhesive, amphiphilic chitosan that may serve as an anti-viral nasal spray. Pyrć K; Milewska A; Duran EB; Botwina P; Dabrowska A; Jedrysik M; Benedyk M; Lopes R; Arenas-Pinto A; Badr M; Mellor R; Kalber TL; Fernandez-Reyes D; Schätzlein AG; Uchegbu IF Sci Rep; 2021 Oct; 11(1):20012. PubMed ID: 34625610 [TBL] [Abstract][Full Text] [Related]
12. Cyclosporine A micellar nasal spray characterization and antiviral action against SARS-CoV-2. Guareschi F; Del Favero E; Ricci C; Cantù L; Brandolini M; Sambri V; Nicoli S; Pescina S; D'Angelo D; Rossi I; Buttini F; Bettini R; Sonvico F Eur J Pharm Sci; 2024 Feb; 193():106673. PubMed ID: 38103657 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of Coronavirus Entry Outlaw VK; Bovier FT; Mears MC; Cajimat MN; Zhu Y; Lin MJ; Addetia A; Lieberman NAP; Peddu V; Xie X; Shi PY; Greninger AL; Gellman SH; Bente DA; Moscona A; Porotto M mBio; 2020 Oct; 11(5):. PubMed ID: 33082259 [TBL] [Abstract][Full Text] [Related]
14. Nasal Spray of Neutralizing Monoclonal Antibody 35B5 Confers Potential Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern: A Small-Scale Clinical Trial. Lin Y; Yue S; Yang Y; Yang S; Pan Z; Yang X; Gao L; Zhou J; Li Z; Hu L; Tang J; Wu Q; Lei S; Tian Q; Wang Y; Hao Y; Xu L; Huang Q; Zhu B; Chen Y; Chen X; Ye L Clin Infect Dis; 2023 Feb; 76(3):e336-e341. PubMed ID: 35666466 [TBL] [Abstract][Full Text] [Related]
15. A study protocol for a double-blind randomised placebo-controlled trial evaluating the efficacy of carrageenan nasal and throat spray for COVID-19 prophylaxis-ICE-COVID. Jessop ZM; Gibson J; Lim JY; Jovic TH; Combellack E; Dobbs TD; Carter K; Hiles S; Islam S; Healy B; Humphreys I; Eccles R; Hutchings HA; Whitaker IS Trials; 2022 Sep; 23(1):782. PubMed ID: 36109791 [TBL] [Abstract][Full Text] [Related]
16. Antiviral Activity of the Propylamylatin Brown AN; Strobel G; Hanrahan KC; Sears J Viruses; 2021 Mar; 13(3):. PubMed ID: 33807769 [TBL] [Abstract][Full Text] [Related]
17. Virucidal activity of nasal sprays against severe acute respiratory syndrome coronavirus-2. Meister TL; Todt D; Brüggemann Y; Steinmann J; Banava S; Brill FHH; Steinmann J; Pfaender S; Steinmann E J Hosp Infect; 2022 Feb; 120():9-13. PubMed ID: 34752803 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of in vitro activity of copper gluconate against SARS-CoV-2 using confocal microscopy-based high content screening. Rodriguez K; Saunier F; Rigaill J; Audoux E; Botelho-Nevers E; Prier A; Dickerscheit Y; Pillet S; Pozzetto B; Bourlet T; Verhoeven PO J Trace Elem Med Biol; 2021 Dec; 68():126818. PubMed ID: 34274845 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of acid sphingomyelinase by ambroxol prevents SARS-CoV-2 entry into epithelial cells. Carpinteiro A; Gripp B; Hoffmann M; Pöhlmann S; Hoertel N; Edwards MJ; Kamler M; Kornhuber J; Becker KA; Gulbins E J Biol Chem; 2021; 296():100701. PubMed ID: 33895135 [TBL] [Abstract][Full Text] [Related]
20. Diltiazem inhibits SARS-CoV-2 cell attachment and internalization and decreases the viral infection in mouse lung. Wang X; Luo J; Wen Z; Shuai L; Wang C; Zhong G; He X; Cao H; Liu R; Ge J; Hua R; Sun Z; Wang X; Wang J; Bu Z PLoS Pathog; 2022 Feb; 18(2):e1010343. PubMed ID: 35176124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]